Colin-Jones DG - Search Results

1

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs.

Langman MJ, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RF, Murphy M, Vessey MP, Colin-Jones DG. Langman MJ, et al. Lancet. 1994 Apr 30;343(8905):1075-8. doi: 10.1016/s0140-6736(94)90185-6. Lancet. 1994. PMID: 7909103

2

Prophylactic aspirin and risk of peptic ulcer bleeding.

Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, Rawlins M, Vessey M, Wainwright P. Weil J, et al. BMJ. 1995 Apr 1;310(6983):827-30. doi: 10.1136/bmj.310.6983.827. BMJ. 1995. PMID: 7711618 Free PMC article.

3

Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs.

Weil J, Langman MJ, Wainwright P, Lawson DH, Rawlins M, Logan RF, Brown TP, Vessey MP, Murphy M, Colin-Jones DG. Weil J, et al. Among authors: colin jones dg. Gut. 2000 Jan;46(1):27-31. doi: 10.1136/gut.46.1.27. Gut. 2000. PMID: 10601050 Free PMC article.

4

Alzheimer's disease in antacid users.

Colin-Jones D, Langman MJ, Lawson DH, Vessey MP. Colin-Jones D, et al. Lancet. 1989 Jun 24;1(8652):1453. doi: 10.1016/s0140-6736(89)90159-1. Lancet. 1989. PMID: 2567461 No abstract available.

5

Mortality study of 18 000 patients treated with omeprazole.

Bateman DN, Colin-Jones D, Hartz S, Langman M, Logan RF, Mant J, Murphy M, Paterson KR, Rowsell R, Thomas S, Vessey M; SURVEIL (Study of Undetected Reactions, Vigilance Enquiry into Links) Group. Bateman DN, et al. Gut. 2003 Jul;52(7):942-6. doi: 10.1136/gut.52.7.942. Gut. 2003. PMID: 12801948 Free PMC article.

6

Postmarketing surveillance of the safety of cimetidine: 15-year mortality report.

Beresford J, Colin-Jones DG, Flind AC, Langman MJ, Lawson DH, Logan RF, Paterson KR, Vessey MP. Beresford J, et al. Among authors: colin jones dg. Pharmacoepidemiol Drug Saf. 1998 Sep;7(5):319-22. doi: 10.1002/(SICI)1099-1557(199809/10)7:5<319::AID-PDS367>3.0.CO;2-K. Pharmacoepidemiol Drug Saf. 1998. PMID: 15073978

7

Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study.

Colin-Jones DG, Langman MJ, Lawson DH, Vessey MP. Colin-Jones DG, et al. Br Med J (Clin Res Ed). 1982 Nov 6;285(6351):1311-3. doi: 10.1136/bmj.285.6351.1311. Br Med J (Clin Res Ed). 1982. PMID: 6812688

8

Routine practice in the diagnosis of adenocarcinoma of the stomach: a survey of tumours diagnosed in the Portsmouth and Oxford Health Districts 1979-1980.

Deakin M, Colin-Jones DG, Vessey MP. Deakin M, et al. Postgrad Med J. 1988 Jan;64(747):33-7. doi: 10.1136/pgmj.64.747.33. Postgrad Med J. 1988. PMID: 3420055 Free PMC article.

9

Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up.

Colin-Jones DG, Langman MJ, Lawson DH, Vessey MP. Colin-Jones DG, et al. Br Med J (Clin Res Ed). 1985 Oct 19;291(6502):1084-8. doi: 10.1136/bmj.291.6502.1084. Br Med J (Clin Res Ed). 1985. PMID: 3931805 Free PMC article.

10

Post-cimetidine surveillance for up to ten years: incidence of carcinoma of the stomach and oesophagus.

Colin-Jones DG, Langman MJ, Lawson DH, Logan RF, Paterson KR, Vessey MP. Colin-Jones DG, et al. Q J Med. 1991 Jan;78(285):13-9. Q J Med. 1991. PMID: 1670060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page